Stereotaxis, Inc. (NYSE:STXS) Q1 2019 Earnings Conference Call May 9, 2019 9:00 AM ET Company Participants David Fischel - CEO & Chairman Martin Stammer - CFO Conference Call Participants Joshua Jennings - Cowen and Company Operator Good morning. Thank you for joining us for Stereotaxis First Quarter 2019 Earnings Conference Call. Certain statements during the conference call and question-and-answer period to follow may relate to future events, expectations and, as such, constitute forward-looking statement ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (MARK ONE) [X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED DECEMBER 31, 2018 OR [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO COMMISSION FILE NUMBER 001-36159 STEREOTAXIS, INC. (Exact name of the Registrant as Specified in its Charter) DELAWARE 94-3120386 (State or Other Jurisdicti ...

Stereotaxis, Inc. (NYSE:STXS) Q4 2018 Earnings Conference Call March 12, 2019 10:00 AM ET Company Representatives David Fischel - Chairman, Chief Executive Officer Marty Stammer - Chief Financial Officer Conference Call Participants Chris Vaster - Private Investor Operator Good morning. Thank you for joining us for the Stereotaxis Fourth Quarter and Full Year 2018 Earnings Conference Call. Certain statements during the conference call and question-and-answer session to follow may relate to future events, ex ...

Investor Presentation 4Q 2018 2 Stereotaxis at a Glance Global Leader in Endovascular Robotics Focused on the Treatment of Cardiac Arrhythmias Extensive Presence 300+ Physicians | 100+ Active Systems | 31 Countries . Validated & Protected 100,000+ Procedures | 300+ Publications | 100+ Issued Patents. Attractive Market $4B+ Existing Market | 10-15% Annual Growth | No Robotic Competitor Financial Highlights* >$30m Sales | >80% Recurring Revenue | >75% Gross Margin . $12.0m Cash and No Debt Enterprise Value ~$ ...